HeXun Biosciences Co., Ltd. (TPEX: 6986)
Health Care · Life Sciences Tools & Services · TW
NT$44.30
+0.68% today · -26.2% 1Y
HeXun Biosciences Co., Ltd. (TPEX: 6986) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $72.23M and employs 53 people.
Over the last twelve months the share price has lost 26.2%, trading between 39.40 and 71.60.
Tweenvest scores HeXun Biosciences Co., Ltd. across four factors: quality 78/100, value 84/100, dividend 12/100. Its strongest factor is value.
6986 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $72.23M
- Revenue (TTM)
- $9.69M
- P/E
- 17.57
- EPS
- 2.52
- Dividend yield
- 0.50%
- Beta (5Y)
- 0.07
- 52-week high
- NT$71.60
- 52-week low
- NT$39.40
- Avg volume (3M)
- —
- Shares outstanding
- 52.13M
- Employees
- 53
- Next earnings
- —
About HeXun Biosciences Co., Ltd.
HeXun Biosciences Co., Ltd., a Taiwanese enterprise, focuses on the research, development, and application of stem cell technologies and treatments. The company also offers a comprehensive suite of related services, including contract development and manufacturing for various cell types and their derivatives, outsourced production capabilities, quality control inspections, expert consulting, laboratory information management system (LIMS) implementation, and sterile (aseptic) filling solutions. Founded in 2019, its operations are headquartered in Taoyuan City, Taiwan.
- ISIN
- TW0006986003
- Founded
- 2019
- Listed since
- Sep 7, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ryvu Therapeutics S.A.WSE: RVU | $97.37M | zł17.14 | +3.88% |
| Celemics, Inc.KOSDAQ: A331920 | $90.08M | ₩10,830.00 | +1.50% |
| HLB bioStep Co.,Ltd.KOSDAQ: A278650 | $80.75M | ₩6,310.00 | +119.48% |
| Nanoform Finland OyjHLSE: NANOFH | $74.13M | €0.76 | -1.55% |
| DreamCIS, Inc.KOSDAQ: A223250 | $71.00M | ₩3,880.00 | +0.13% |
| MindWalk Holdings Corp.NasdaqCM: HYFT | $70.43M | $1.42 | -5.02% |
| Xlife Sciences AGSWX: XLS | $68.02M | CHF9.80 | -4.85% |
| Champions Oncology, Inc.NasdaqCM: CSBR | $67.37M | $4.80 | -0.83% |
Figures last refreshed Oct 11, 2026.